Bayer Debuts Industry-First PET Blister Packaging for Aleve, Pioneering Sustainable Change in Healthcare Packaging

Bayer has launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Reali...

October 31, 2024 | Thursday | News
Oxford Medical Products Announces Promising Topline Results from First RCT of Sirona Weight Loss Technology

 Oxford Medical Products is pleased to announce positive topline results from the first randomised controlled trial (RCT) of Sirona, its innova...

October 31, 2024 | Thursday | News
PolTREG’s Early Treatment with PTG-007 Could Offer Functional Cure for Children at Risk of Type 1 Diabetes

Treating diabetes patients earlier with PTG-007 could provide functional cure Recruitment will go ahead after European Medicines Agency approval Comp...

October 24, 2024 | Thursday | News
Sanofi and CD&R Announce Exclusive Negotiations for 50% Stake in Opella, Poised to Create Global Consumer Healthcare Leader

 Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. S...

October 22, 2024 | Tuesday | News
Dräger India Launches BabyRoo® TN 300, Transforming Newborn Care with Advanced Thermoregulation and Family-Centered Technologies

Dräger India is proud to announce the launch of the BabyRoo® TN 300 open warmer, with state-of-the-art thermoregulation capabilities as well as ad...

October 10, 2024 | Thursday | News
Roche Survey Reveals Half of Global Respondents Unaware of HPV’s Link to Cervical Cancer, Urging Immediate Action

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with ne...

October 08, 2024 | Tuesday | Reports
Oncocyte's GraftAssure™ Assay Adopted by Top U.S. and German Transplant Hospitals, Progresses Toward FDA Submission

GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volume Company clears first stage...

October 03, 2024 | Thursday | News
NextGen Healthcare Expands AI-Driven Ambient Listening to Ophthalmologists and Optometrists

  NextGen Healthcare announced that its AI-driven ambient listening solution NextGen® Ambient Assist is now available to ophthalmologists and opt...

October 02, 2024 | Wednesday | News
LeaderMed and Combiphar Form Joint Venture to Launch Phase 3 Trial of Novel Diabetes Treatment in Indonesia

LeaderMed Group (LeaderMed), a global pharmaceutical development company, and Combiphar, a leading Indonesian pharmaceutical company in Southeast Asia, ann...

October 01, 2024 | Tuesday | News
Astellas Launches DIGITIVA™, a New Digital Health Solution for Heart Failure Management

New digital health solution for heart failure management puts patients at the center of their care by providing ability for at-home disease monitoring -...

September 19, 2024 | Thursday | News
Roche's Xofluza Shows Single-Dose Can Reduce Influenza Transmission in Landmark Global Study

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members This is the f...

September 19, 2024 | Thursday | News
Novartis Announces FDA Approval of Kisqali® for Expanded Use in Early Breast Cancer, Doubling Eligible Patient Population

– Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Kisqali® (ribociclib) in combination with an aromata...

September 18, 2024 | Wednesday | News
Japan Approves World's First Self-Amplifying mRNA COVID-19 Vaccine, KOSTAIVE®, Targeting Omicron JN.1 Subvariants

Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral disea...

September 13, 2024 | Friday | News
Oneness Biotech and Microbio's Pan-COVID Drug SNS812 Achieves Key Phase 2 Trial Success, Showing Broad-Spectrum Efficacy

Oneness Biotech and Microbio (Shanghai) announced that the pan-COVID New Drug, SNS812, co-developed by both companies achieves statistical significance wit...

September 11, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close